Commentary Volume 7 Issue 5
1School of Kinesiology, Western University, Canada
2Department of Neuroscience, Western University, Canada
Correspondence: Lindsay S Nagamatsu, School of Kinesiology, Western University, 3M Centre, Room 2225, London, ON, Canada, Tel 519661211182659, Fax 5196613092
Received: December 13, 2017 | Published: December 21, 2017
Citation: Nagamatsu LS, Furlano JA. Improving executive function for better diabetes management. Adv Obes Weight Manag Control. 2017;7(5):351-352. DOI: 10.15406/aowmc.2017.07.00213
Type 2 diabetes (T2D) is a global healthcare epidemic. In addition to physical consequences of the disease, T2D patients also experience cognitive decline. Importantly, intact cognitive function - and in particular, executive functioning - is essential for management of the disease. One way to improve executive functions is through exercise; indeed, there is a growing body of research that suggests that both aerobic- and resistance-training can improve aspects of executive function, both behaviorally and through changes in functional activation in the brain. Thus, we contend that improving executive function through strategic exercise interventions has the potential to both directly and indirectly impact the management and progression of the disease in T2D patients. Future directions and recommendations are discussed.
Keywords: exercise, type 2 diabetes, T2D, cognitive function, executive function
Diabetes has become an epidemic in the United States, with over 30million people currently affected, the majority of which have type 2 diabetes (T2D).1 At the societal level, it is the seventh leading cause of death in the US, and the burden on the health care system is estimated at $245 billion in direct and indirect costs.1 Secondary consequences of T2D include microvascular and macrovascular complications, including neuropathy, coronary artery disease, and stroke. However, it is now widely recognized that patients with T2D also experience reduced cognitive function and are at greater risk for dementia and Alzheimer’s disease.2 For example, in a large prospective study of more than 9,000 older women, those with diabetes had significantly worse cognitive performance at baseline and at six-year follow-up compared to their non-diabetic counterparts.3 Furthermore, dementia and T2D often co-occur, with up to 81% of older adults with dementia also having diabetes or impaired fasting glucose.4 Cognitive decline in T2D patients is a major concern because it can directly impact the management of the disease. Specifically, lifestyle modifications (e.g., diet and exercise) and self-management (e.g., monitoring of glucose levels and medication use) serve as the foundation for controlling the symptoms and trajectory of T2D. However, effective adoption and adherence to such strategies relies on executive functions – our higher level goal-directed cognitive processes, such as planning, conflict monitoring, and inhibition; indeed, previous research has linked executive functioning to engagement in health behaviours. Specifically, performance on the Stroop task significantly predicted smoking, substance abuse, and sleep habits in a sample of 217 adults.5 Further evidence comes from a cross-sectional study of 1,398 older adults with diabetes where those with greater cognitive impairment had lower adherence to both diet and exercise.6 Thus, improving executive functioning in those with T2D may positively impact management and progression of the disease. As evidence, in a ten year prospective study, performance on a test of executive functioning predicted survival time in those diagnosed with a chronic illness, including T2D.7
One theory explaining this connection between executive functioning and health behaviours is temporal self-regulation theory, which proposes that regulating our health behaviours requires the engagement of neurocognitive processes - and more specifically, executive functions.8 In particular, we must inhibit our temptation to give in to short term rewards, focusing instead on the potential long-term benefits.8 A common example is the decision to go to the gym, compromising the short-term consequences of the time commitment and uncomfortable feeling of exercising, with the long-term goal of improving future fitness and health. Success in this scenario requires our executive functions to inhibit, plan, and make complex decisions.
Based on the above, it would stand to reason that improving executive functioning would lead to better self-regulation, and therefore increase adherence to behaviours necessary to manage one’s current disease state. One proposed method for improving executive functioning is through exercise. There is a growing body of literature to support the idea that both aerobic (AT) and resistance (RT) training can improve behavioural measures of executive functioning, as well as facilitate functional and structural plasticity in the brain. For example, Colcombe and colleagues9 found that healthy older adults who engaged in six months of thrice-weekly walking improved their performance on the flanker task, a test of response inhibition, and showed increased activation in frontal and parietal brain regions and decreased activation in the anterior cingulate cortex – exactly the regions of the brain required to regulate our health behaviours.8 These benefits to cognition from exercise have also been demonstrated in those with glucose intolerance, where older adults randomized to a six-month aerobic exercise group significantly improved their executive function compared to controls.10
While the majority of research on the effects of exercise on cognition have focused on AT, RT has also shown positive results. For example, twice weekly progressive resistance training has been shown to improve behavioural measures of executive function and result in functional brain plasticity in both healthy older women11,12 and those with mild cognitive impairment.13,14 Importantly, RT may provide even greater benefits to those with diabetes. In particular, one mechanism through which RT has been hypothesized to exert its impact on neural plasticity is through increasing levels of insulin-like growth factor 1 (IGF-1).15 Low levels of IGF-1 have been associated with increased risk of T2D,16 and may contribute to the cognitive deficits observed in this population. Because RT has additional benefits (e.g., improved skeletal muscle and bone health) in T2D patients17 and provides them with an alternative form of exercise which may increase uptake and adherence, we propose that future studies should examine the effects of RT on cognition in T2D patients. We contend that exercise is a promising strategy to not only mitigate the physical risk factors associated with T2D, but also the cognitive risk factors, which may in turn, improve physical factors through adherence to health strategies. Questions that remain to be answered include:
Based on the above, the potential for exercise to improve T2D outcomes both directly and indirectly is clear. Notably, exercise is a promising, cost-effective, and scalable solution to improve executive function in those with T2D, and may result in increased quality of life and longevity in this high-risk patient population.
Thus, we conclude that large-scale high quality randomized controlled trials (RCTs) with executive function as the primary outcome are necessary to elucidate the potential benefits of exercise on the brain as well as the body in T2D patients.
This work was supported by funds awarded from Western’s Strategic Support for CIHR Success program.
The author declares no conflict of interest.
©2017 Nagamatsu, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.